TickerGuard
Buy Day today: Neutral (59) Mixed market breadth · major macro event coming up
ARGX

argenx NV

Healthcare · Biotechnology

856.90$ -2.2% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Cash Flow

argenx NV (ARGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 850 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ARGX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-6.4 -15 11 -44 -62 152 -398 -607 -863 -420 -83 850
0.2 0.2 0.4 0.5 0.6 2.4 3.9 5.9 104 111 18 28
1.2 2.5 3.0 5.1 22 44 97 179 157 233 235 248
0.6 2.1 2.8 9.4 3.4 18 190 137 118
5.4 -0.8 30 -22 10 310 -28 -341 -376 -309 -325 -424
0.2 0.3 0.9 0.4 0.8 47 5.1 121 104 44 68 6.2
-28 18 -0.8 -194 -123 -833 345 -347 -461 308 -718 824
0.0 0.0 0.0 0.0 0.0 0.0 5.5
50 57,795,530 4,762,335 1,000,000,000,000 0.0 0.0 -5.5 -12 -22
0.0 0.0 -1.4 -1.4 -1.4 -1.4 -2.2 -3.9 -4.2 -3.8 -7.6 -4.1
46 0.3 47 366 280 734 833 1,121 844 1,337 280 234
12 3.6 57 121 103 50 845 118 -534 1,248 -549 1,991
-6.6 -15 10 -44 -62 105 -404 -728 -967 -464 -151 844

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?